LSTM Home > LSTM Research > LSTM Online Archive

Animal derived antibodies should be considered alongside convalescent human plasma to deliver treatments for COVID-19

Downloads

Downloads per month over past year

Ainsworth, Stuart ORCID: https://orcid.org/0000-0002-0199-6482, Menzies, Stefanie and Pleass, Richard ORCID: https://orcid.org/0000-0001-7438-8296 (2020) 'Animal derived antibodies should be considered alongside convalescent human plasma to deliver treatments for COVID-19'. Wellcome Open Research, Vol 5, Issue 115.

[img]
Preview
Text
Ainsworth et al 2020_Animal derived antibodies_Wellcome Open Res-June-20.pdf - Published Version
Available under License Creative Commons Attribution.

Download (609kB) | Preview

Abstract

Published data on the first 5,000 coronavirus patients to receive plasma shows promise in the United States. However, delivering convalescent plasma therapies in low- and even middle-income countries is both difficult and costly. Here we discuss the advantages and disadvantages of antisera raised in animals that may

Item Type: Article
Subjects: QW Microbiology and Immunology > Antigens and Antibodies. Toxins and Antitoxins > QW 575 Antibodies
WA Public Health > WA 105 Epidemiology
WC Communicable Diseases > Virus Diseases > Viral Respiratory Tract Infections. Respirovirus Infections > WC 505 Viral respiratory tract infections
WH Hemic and Lymphatic Systems > Hematologic Diseases. Immunologic Factors. Blood Banks > WH 400 Fluid elements. Plasma. Serum. Blood proteins. Blood protein disorders
Faculty: Department: Biological Sciences > Department of Tropical Disease Biology
Digital Object Identifer (DOI): https://doi.org/10.12688/wellcomeopenres.15990.1
Depositing User: Mary Creegan
Date Deposited: 22 Jun 2020 12:21
Last Modified: 22 Jun 2020 12:21
URI: https://archive.lstmed.ac.uk/id/eprint/14769

Statistics

View details

Actions (login required)

Edit Item Edit Item